Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity
出版年份 2021 全文链接
标题
Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity
作者
关键词
-
出版物
JOURNAL OF MEDICINAL CHEMISTRY
Volume 64, Issue 24, Pages 18082-18101
出版商
American Chemical Society (ACS)
发表日期
2021-12-09
DOI
10.1021/acs.jmedchem.1c01496
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta
- (2021) Nan Bai et al. Journal of Chemical Information and Modeling
- PROTACs and Building Blocks: The 2D Chemical Space in Very Early Drug Discovery
- (2021) Giuseppe Ermondi et al. MOLECULES
- Fundamental aspects of DMPK optimization of targeted protein degraders
- (2020) Carina Cantrill et al. DRUG DISCOVERY TODAY
- Assays and technologies for developing proteolysis targeting chimera degraders
- (2020) Xingui Liu et al. Future Medicinal Chemistry
- First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).
- (2020) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted protein degradation: current and future challenges
- (2020) Alexander Hanzl et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Degraders early developability assessment: face-to-face with molecular properties
- (2020) Giuseppe Ermondi et al. DRUG DISCOVERY TODAY
- Targeting Estrogen Receptor α for degradation with PROTACs: A Promising Approach to Overcome Endocrine Resistance
- (2020) Xin Lin et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phosphorylation-Inducing Chimeric Small Molecules
- (2020) Sachini U. Siriwardena et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Understanding and Improving the Membrane Permeability of VH032-Based PROTACs
- (2020) Victoria G. Klein et al. ACS Medicinal Chemistry Letters
- Systematic Investigation of the Permeability of Androgen Receptor PROTACs
- (2020) Duncan E. Scott et al. ACS Medicinal Chemistry Letters
- Solution Conformations Shed Light on PROTAC Cell Permeability
- (2020) Yoseph Atilaw et al. ACS Medicinal Chemistry Letters
- The PROTAC technology in drug development
- (2019) Yutian Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)
- (2019) Jiantao Hu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
- (2019) Blake E. Smith et al. Nature Communications
- Drug–Membrane Permeability across Chemical Space
- (2019) Roberto Menichetti et al. ACS Central Science
- SPR-Measured Dissociation Kinetics of PROTAC Ternary Complexes Influence Target Degradation Rate
- (2019) Michael J. Roy et al. ACS Chemical Biology
- Proteolysis targeting chimeras (PROTACs) in ‘beyond rule-of-five’ chemical space: Recent progress and future challenges
- (2019) Scott D. Edmondson et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- (2019) William Farnaby et al. Nature Chemical Biology
- Degradation of proteins by PROTACs and other strategies
- (2019) Yang Wang et al. Acta Pharmaceutica Sinica B
- Arvinas’s PROTACs pass first safety and PK analysis
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay
- (2019) Caroline A. Foley et al. ACS Chemical Biology
- Structure-Based Design of a Macrocyclic PROTAC
- (2019) Andrea Testa et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- AUTACs: Cargo-Specific Degraders Using Selective Autophagy
- (2019) Daiki Takahashi et al. MOLECULAR CELL
- Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action
- (2018) Kristin M. Riching et al. ACS Chemical Biology
- Two Decades under the Influence of the Rule of Five and the Changing Properties of Approved Oral Drugs
- (2018) Michael D. Shultz JOURNAL OF MEDICINAL CHEMISTRY
- Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
- (2018) Sainan An et al. EBioMedicine
- Lipophilic Permeability Efficiency Reconciles the Opposing Roles of Lipophilicity in Membrane Permeability and Aqueous Solubility
- (2018) Matthew R. Naylor et al. JOURNAL OF MEDICINAL CHEMISTRY
- Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
- (2018) Vittoria Zoppi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Addressing Kinase-Independent Functions of Fak via PROTAC-Mediated Degradation
- (2018) Philipp M. Cromm et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Molecular recognition of ternary complexes: a new dimension in the structure-guided design of chemical degraders
- (2017) Scott J. Hughes et al. Essays in Biochemistry
- Group-Based Optimization of Potent and Cell-Active Inhibitors of the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase: Structure–Activity Relationships Leading to the Chemical Probe (2S,4R)-1-((S)-2-(1-Cyanocyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide (VH298)
- (2017) Pedro Soares et al. JOURNAL OF MEDICINAL CHEMISTRY
- How Big Is Too Big for Cell Permeability?
- (2017) Pär Matsson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Impact of Target Warhead and Linkage Vector on Inducing Protein Degradation: Comparison of Bromodomain and Extra-Terminal (BET) Degraders Derived from Triazolodiazepine (JQ1) and Tetrahydroquinoline (I-BET726) BET Inhibitor Scaffolds
- (2017) Kwok-Ho Chan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nonclassical Size Dependence of Permeation Defines Bounds for Passive Adsorption of Large Drug Molecules
- (2017) Cameron R. Pye et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
- (2017) Ian Churcher JOURNAL OF MEDICINAL CHEMISTRY
- Structural basis of PROTAC cooperative recognition for selective protein degradation
- (2017) Morgan S Gadd et al. Nature Chemical Biology
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Passive Membrane Permeability in Cyclic Peptomer Scaffolds Is Robust to Extensive Variation in Side Chain Functionality and Backbone Geometry
- (2016) Akihiro Furukawa et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
- (2015) Michael Zengerle et al. ACS Chemical Biology
- Improving the passive permeability of macrocyclic peptides: Balancing permeability with other physicochemical properties
- (2015) Praew Thansandote et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Exploring experimental and computational markers of cyclic peptides: Charting islands of permeability
- (2015) Conan K. Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Going Out on a Limb: Delineating The Effects of β-Branching, N-Methylation, and Side Chain Size on the Passive Permeability, Solubility, and Flexibility of Sanguinamide A Analogues
- (2015) Andrew T. Bockus et al. JOURNAL OF MEDICINAL CHEMISTRY
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
- (2014) Bradley Croy Doak et al. CHEMISTRY & BIOLOGY
- Structure-Guided Design and Optimization of Small Molecules Targeting the Protein–Protein Interaction between the von Hippel–Lindau (VHL) E3 Ubiquitin Ligase and the Hypoxia Inducible Factor (HIF) Alpha Subunit with in Vitro Nanomolar Affinities
- (2014) Carles Galdeano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Intracellular drug concentration and disposition – The missing link?
- (2014) Michael M. Hann et al. METHODS
- P-Glycoprotein Mediated Efflux Limits the Transport of the Novel Anti-Parkinson's Disease Candidate Drug FLZ across the Physiological and PD Pathological In Vitro BBB Models
- (2014) Qian Liu et al. PLoS One
- Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients
- (2014) Conan K. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrating Intramolecular Hydrogen Bonding (IMHB) Considerations in Drug Discovery Using ΔlogP As a Tool
- (2013) Marina Shalaeva et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Comprehensive Mathematical Model for Three-Body Binding Equilibria
- (2013) Eugene F. Douglass et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface
- (2012) Inge Van Molle et al. CHEMISTRY & BIOLOGY
- The influence of lipophilicity in drug discovery and design
- (2012) John A Arnott et al. Expert Opinion on Drug Discovery
- Getting physical in drug discovery II: the impact of chromatographic hydrophobicity measurements and aromaticity
- (2011) Robert J. Young et al. DRUG DISCOVERY TODAY
- Discovery and Characterization of Small Molecule Inhibitors of the BET Family Bromodomains
- (2011) Chun-wa Chung et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Effect of Multiple N-Methylation on Intestinal Permeability of Cyclic Hexapeptides
- (2011) Oded Ovadia et al. MOLECULAR PHARMACEUTICS
- Lipophilicity in drug discovery
- (2010) Michael J Waring Expert Opinion on Drug Discovery
- Impact of linker length on the activity of PROTACs
- (2010) Kedra Cyrus et al. Molecular BioSystems
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Improving Oral Bioavailability of Peptides by Multiple N-Methylation: Somatostatin Analogues
- (2008) Eric Biron et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started